FDA Issues Suicidality Alert On Antiepileptics
This article was originally published in The Pink Sheet Daily
Executive Summary
A class-wide relabeling is expected, but Pfizer says that Neurontin and Lyrica show no signs of increased events.
You may also be interested in...
Should FDA Drug Safety Alerts Go To Professionals First?
Physicians need to know about drug safety problems before their patients hear about them, Steven Schachter, president of the American Epilepsy Society, told the FDA Transparency Task Force June 24
Should FDA Drug Safety Alerts Go To Professionals First?
Physicians need to know about drug safety problems before their patients hear about them, Steven Schachter, president of the American Epilepsy Society, told the FDA Transparency Task Force June 24
Keppra Gets Six-Month Pediatric Exclusivity
FDA clearance will keep generic versions of the epilepsy drug off the market until Nov. 1.